U.S. Electronic Equipment and Components Stock News

Biotech sentiment has improved following an FDA leadership change that investors view as easing regulatory hurdles for cell and gene therapies. PTC Therapeutics, listed as NasdaqGS:PTCT, is among the companies seen as directly affected by this shift in perceived regulatory risk. The change centers on the departure of an official viewed as cautious on accelerated approvals, which is drawing fresh attention to PTC's drug pipeline. For PTC Therapeutics, trading at $65.67, this regulatory...

Kennametal executive Ellen Whittingham has been named a 2026 STEP Ahead Award Honoree. The award recognizes her leadership and work in talent development within the manufacturing sector. This recognition highlights Kennametal's focus on workplace culture and leadership depth at NYSE:KMT. Kennametal, listed on NYSE:KMT, supplies tooling and industrial materials to customers across metalworking and related manufacturing fields. Recognition for an executive focused on leadership and talent...

If you are wondering whether Rithm Capital’s current share price reflects its true worth, you are not alone, especially with income focused financial stocks back on many watchlists. The stock last closed at US$9.87, with returns of 1.1% over 7 days but declines of 7.3% over 30 days, 10.1% year to date, and 5.7% over 1 year. However, the 3 year and 5 year returns of 64.6% and 41.6% show a very different picture for longer term holders. Recent coverage has focused on Rithm Capital’s position...

What FuelCell Energy’s Latest Earnings Tell You FuelCell Energy (FCEL) just reported Q1 2026 results, with revenue of US$30.53 million, sales of US$10.99 million, and a net loss of US$22.86 million, alongside a smaller loss per share year over year. See our latest analysis for FuelCell Energy. FuelCell Energy’s shares have been under pressure despite the Q1 2026 revenue lift and narrower loss. The 7 day share price return shows a 17.04% decline and the 90 day share price return shows an...

Blend Labs (BLND) just posted its FY 2025 fourth quarter numbers, with revenue of US$32.4 million and a basic EPS loss of US$0.03, while net income excluding extra items came in at a loss of US$7.1 million. The company has seen quarterly revenue move from US$41.4 million in Q4 2024 to US$32.4 million in Q4 2025, with basic EPS shifting from a loss of US$0.03 in Q4 2024 to a loss of US$0.03 in the latest quarter. As a result, this reporting period is likely to draw attention to how the loss...

If you are wondering whether Qualys shares are starting to look interesting, this article will walk through how the current price lines up against the underlying business. The stock last closed at US$96.66, with returns of a 1.4% decline over 7 days, an 11.4% decline over 30 days, a 26.2% decline year to date, and a 21.5% decline over the past year, which may influence how investors are thinking about both growth potential and risk. Over the past few months, Qualys has continued to feature...

If you are wondering whether Strategic Education's current share price still represents solid value, the recent data gives you plenty to think about. The stock closed at US$78.87 recently, with returns of a 3.3% decline over 7 days and a 1.3% decline over 30 days, while year to date it is up 0.4% and the 1-year return sits at 1.6%. These steady but modest return figures over the past year, including 0.8% over 3 years and 4.6% over 5 years, suggest the market has been cautious in how it...

Global Business Travel Group (NYSE:GBTG) has completed its acquisition of CWT, reaching what management calls an inflection point in its business transformation. The company is rolling out Egencia AI, which management says is already contributing to measurable revenue and cost efficiencies. GBTG reports strong revenue growth and profitability in 2025 alongside accelerated integration, restructuring, and productivity efforts. For investors watching NYSE:GBTG, the share price at $5.57 sits...

Transocean has completed an all stock acquisition of Valaris, combining two major offshore drilling companies. The deal significantly expands Transocean's offshore rig fleet and contract portfolio. Management expects cost synergies and a stronger competitive position in the global offshore drilling market. For investors watching NYSE:RIG, this merger follows a period of strong share price moves, with the stock up 48.8% year to date and 111.7% over the past year, closing at $6.31. The...

If you are wondering whether Preformed Line Products is still offering value after a strong run, this article walks through what the current share price might be implying about the business. The stock closed at US$267.23 recently, with returns of 4.6% over 7 days, a 2.5% decline over 30 days, 26.1% year to date and 118.3% over the past year, as well as 135.3% over 3 years and 271.3% over 5 years. Recent attention on grid reliability, utility infrastructure and related capital projects has...

Lantronix (LTRX) is back on investor radars after expanding its embedded compute portfolio with new MediaTek based System on Module solutions and signing a European distribution deal with Melchioni Electronics. See our latest analysis for Lantronix. The recent MediaTek based SOM launch and the Melchioni distribution deal arrive after a mixed stretch for the stock, with a 7 day share price return of 3.89% but a 90 day share price return decline of 6.69%, while the 1 year total shareholder...

uniQure (NasdaqGS:QURE) faces multiple securities class action lawsuits focused on disclosures around its AMT-130 gene therapy program. Federal health officials have criticized the company for alleged data manipulation tied to AMT-130. The FDA has withdrawn support for a Biologics License Application for AMT-130, complicating the program's regulatory path. Upcoming changes in FDA leadership are expected to affect how AMT-130 and related filings are reviewed. These developments arrive at a...

Servier Pharmaceuticals has entered into a definitive agreement to acquire Day One Biopharmaceuticals, NasdaqGS:DAWN, in an all cash transaction. The deal marks a material change in ownership, bringing Day One Biopharmaceuticals under Servier control and ending its status as an independent company once the transaction closes. Day One Biopharmaceuticals focuses on developing and commercializing oncology therapies, a segment that has seen frequent partnerships, licensing arrangements, and...

Domo (DOMO) closed FY 2026 with fourth quarter revenue of US$79.6 million and a basic EPS loss of US$0.19, setting a clear snapshot of where the top line and bottom line currently stand. Over recent periods the company has kept quarterly revenue in a tight band around US$79 million to US$80 million, while basic EPS losses have ranged from US$0.25 to US$0.56 per quarter, giving investors a consistent read on how revenue scale and per share losses are tracking together. With that backdrop, this...

HCA Healthcare (NYSE:HCA) has received the 2026 Patient Safety Excellence Award from Healthgrades for 92 of its hospitals. The recognition highlights strong performance on patient safety and quality metrics across a wide portion of HCA’s hospital network. This award follows earlier 2026 acknowledgments for several HCA facilities as top performers for quality and safety in the US hospital market. HCA Healthcare operates a large network of hospitals and outpatient facilities across the US, so...

Transaction Systems Services (TSS) closed its FY 2025 third quarter with revenue of US$41.9 million, Basic EPS of US$0.06 loss and net income excluding extra items of US$1.5 million loss. The trailing twelve months show revenue of US$234.8 million, Basic EPS of US$0.20 and net income of US$4.9 million. Over recent periods, the company has seen quarterly revenue move between US$12.2 million and US$99.0 million, with Basic EPS ranging from US$0.06 loss to US$0.13 per share. Net income excluding...

Pangaea Logistics Solutions (PANL) just wrapped up FY 2025 with fourth quarter revenue of US$183.9 million and basic EPS of US$0.19, alongside net income of US$11.9 million, in a context where trailing twelve month revenue is US$632.0 million and EPS is US$0.30. Over recent periods, the company’s quarterly revenue moved from US$147.2 million in Q4 2024 to US$183.9 million in Q4 2025. Over the same quarters, basic EPS shifted from US$0.18 to US$0.19. Investors may weigh these changes in...

Tidewater Inc. has reported its fourth quarter and full-year 2025 results, with Q4 revenue of US$336.8 million and a sharp increase in net income to US$219.88 million, alongside full-year revenue of US$1.35 billion and net income of US$334.66 million. Alongside these results, the company issued 2026 revenue guidance of US$1.43–US$1.48 billion, signaling management’s expectations for higher activity levels across its offshore support operations. Now we’ll examine how Tidewater’s stronger 2025...

Kodiak AI (KDK) just wrapped up FY 2025 with Q4 revenue of US$1.1 million and a basic EPS loss of US$0.42. The trailing twelve months show revenue of US$16.5 million and a basic EPS loss of US$5.74. The company reported TTM revenue of US$14.9 million in FY 2024, alongside a basic EPS loss of US$0.79, giving investors a clearer view of how the top line and per share losses have been tracking into this latest result and providing context for the 6.5% revenue growth figure reported over the past...

Why Arq’s halted GAC production matters for investors Arq (ARQ) has paused granular activated carbon production after independent testing highlighted equipment capacity limits. The company has idled its Corbin facility and recorded a non cash impairment charge tied to long lived assets in the fourth quarter of 2025. See our latest analysis for Arq. The halted GAC production, large non cash impairment and wider 2025 loss sit against a weak share price backdrop, with a 30 day share price return...

High Templar Tech (HTT) has put up a punchy set of FY 2025 numbers, with Q3 revenue of C¥8.5 million, basic EPS of C¥2.55 and trailing 12 month EPS of C¥4.86 backed by very large year over year earnings growth and an 18% net profit margin. The company has seen quarterly revenue shift from C¥55.0 million in Q3 2024 to C¥8.5 million in Q3 2025, while basic EPS moved from C¥0.73 to C¥2.55 over the same stretch. This sets up a results season where the key question is how durable this earnings...

Tredegar (TG) has posted its latest FY 2025 numbers with third quarter revenue at about US$194.9 million and basic EPS of roughly US$0.20, alongside trailing twelve month revenue of US$691.2 million and EPS of about US$0.07 that reflects the impact of a US$19.9 million one off loss. The company has seen quarterly revenue move from US$146.0 million in Q3 2024 to US$194.9 million in Q3 2025, while basic EPS has shifted from roughly a US$0.10 loss to about US$0.20. This gives investors a cleaner...

OppFi (OPFI) has delivered a sharp swing in its latest quarter, with Q3 2025 revenue of US$94.5 million and basic EPS of US$1.48, alongside net income of US$41.6 million. The company has reported revenue of US$75.3 million in Q2 2024, US$90.5 million in Q2 2025, and US$94.5 million in Q3 2025. Over the same periods, EPS moved from US$0.16 in Q2 2024 to a loss of US$0.78 in Q2 2025, before rebounding to US$1.48 in Q3 2025. This sets up a results season in which investors are likely to focus...

BETA Technologies, Inc. was recently selected by the U.S. Department of Transportation and Federal Aviation Administration as a launch participant in the first-ever eVTOL Integration Pilot Program, taking part in seven of eight projects to operate its ALIA CTOL and VTOL aircraft and charging infrastructure across at least 10 U.S. states. This broad role in federal trials gives BETA an early chance to prove its aircraft and ground systems in real-world cargo and medical missions alongside...